IPO medmix AG
30. September 2021 – After its spin-off from Sulzer AG (SUN), medmix AG (MEDX) raised CHF 315 million by selling 7 million new shares which are traded at SIX Stock Exchange as of today.
Walder Wyss has advised medmix in this transaction. The team was led by Urs Schenker (Senior Counsel, Transactions/M&A), Dominik Hohler (Partner, Transactions/M&A) and Theodor Härtsch (Partner, Transactions/Finance) and further included i.a. Thomas Meister (Partner, Tax), Janine Corti (Counsel, Tax), Daniel Dedeyan (Counsel, Transactions/Finance), Angela Kummer (Associate, Transactions/M&A), Etienne Trandafir (Associate, Transactions/Finance) and Thomas Nagel (Associate, Transactions/Finance).